Literature DB >> 16954163

Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.

Patrick J Pollard1, Mona El-Bahrawy, Richard Poulsom, George Elia, Pip Killick, Gavin Kelly, Toby Hunt, Rosemary Jeffery, Pooja Seedhar, Julian Barwell, Farida Latif, Michael J Gleeson, Shirley V Hodgson, Gordon W Stamp, Ian P M Tomlinson, Eamonn R Maher.   

Abstract

CONTEXT: Activation of the hypoxia-inducible transcription factors HIF-1 and HIF-2 and a HIF-independent defect in developmental apoptosis have been implicated in the pathogenesis of pheochromocytoma (PCC) associated with VHL, SDHB, and SDHD mutations.
OBJECTIVE: Our objective was to compare protein (HIF-1alpha, EPAS1, SDHB, JunB, CCND1, CD34, CLU) and gene (VEGF, BNIP3) expression patterns in VHL and SDHB/D associated tumors.
RESULTS: Overexpression of HIF-2 was relatively more common in VHL than SDHB/D PCC (12 of 13 vs. 14 of 20, P = 0.02), whereas nuclear HIF-1 staining was relatively more frequent in SDHB/D PCC (19 of 20 vs. 13 of 16, P = 0.04). In addition, CCND1 and VEGF expression (HIF-2 target genes) was significantly higher in VHL than in SDHB/D PCC. These findings suggest that VHL inactivation leads to preferential HIF-2 activation and CCND1 expression as described previously in VHL-defective renal cell carcinoma cell lines but not in other cell types. These similarities between the downstream consequences of VHL inactivation and HIF dysregulation in renal cell carcinoma and PCC may explain how inactivation of the ubiquitously expressed VHL protein results in susceptibility to specific tumor types. Both VHL and SDHB/D PCC demonstrated reduced CLU and SDHB expression. SDHB PCC are associated with a high risk of malignancy, and expression of (proapototic) BNIP3 was significantly lower in SDHB than VHL PCC.
CONCLUSION: Although inactivation of VHL and SDHB/D may disrupt similar HIF-dependent and HIF-independent signaling pathways, their effects on target gene expression are not identical, and this may explain the observed clinical differences in PCC and associated tumors seen with germline VHL and SDHB/D mutations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954163     DOI: 10.1210/jc.2006-0920

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  54 in total

1.  Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemia.

Authors:  Charline Ladroue; David Hoogewijs; Sophie Gad; Romain Carcenac; Federica Storti; Michel Barrois; Anne-Paule Gimenez-Roqueplo; Michel Leporrier; Nicole Casadevall; Olivier Hermine; Jean-Jacques Kiladjian; André Baruchel; Fadi Fakhoury; Brigitte Bressac-de Paillerets; Jean Feunteun; Nathalie Mazure; Jacques Pouysségur; Roland H Wenger; Stéphane Richard; Betty Gardie
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

2.  The Evolving Role of Succinate in Tumor Metabolism: An 18F-FDG-Based Study.

Authors:  Philippe Garrigue; Aurore Bodin-Hullin; Laure Balasse; Samantha Fernandez; Wassim Essamet; Françoise Dignat-George; Karel Pacak; Benjamin Guillet; David Taïeb
Journal:  J Nucl Med       Date:  2017-06-15       Impact factor: 10.057

3.  Determination of the unmetabolised (18)F-FDG fraction by using an extension of simplified kinetic analysis method: clinical evaluation in paragangliomas.

Authors:  Dominique Barbolosi; Sebastien Hapdey; Stephanie Battini; Christian Faivre; Julien Mancini; Karel Pacak; Bardia Farman-Ara; David Taïeb
Journal:  Med Biol Eng Comput       Date:  2015-06-05       Impact factor: 2.602

Review 4.  Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.

Authors:  Lauren Fishbein; Katherine L Nathanson
Journal:  Cancer Genet       Date:  2012 Jan-Feb

Review 5.  Metastatic Phaeochromocytoma: Spinning Towards More Promising Treatment Options.

Authors:  Svenja Nölting; Ashley Grossman; Karel Pacak
Journal:  Exp Clin Endocrinol Diabetes       Date:  2018-09-20       Impact factor: 2.949

Review 6.  Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma.

Authors:  Ales Vicha; David Taieb; Karel Pacak
Journal:  Endocr Relat Cancer       Date:  2014-05-08       Impact factor: 5.678

7.  SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis.

Authors:  Alex Henderson; F Douglas; P Perros; C Morgan; E R Maher
Journal:  Fam Cancer       Date:  2009-01-29       Impact factor: 2.375

8.  Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells.

Authors:  Ana M Cervera; Jean-Pierre Bayley; Peter Devilee; Kenneth J McCreath
Journal:  Mol Cancer       Date:  2009-10-22       Impact factor: 27.401

9.  A legacy of tinnitus: multiple head and neck paragangliomas.

Authors:  Tricia M M Tan; Emma C I Hatfield; Rajesh V Thakker; Eamonn R Maher; Karim Meeran; Niamh M Martin; Jeremy J Turner
Journal:  Rare Tumors       Date:  2009-12-28

10.  The Warburg effect is genetically determined in inherited pheochromocytomas.

Authors:  Judith Favier; Jean-Jacques Brière; Nelly Burnichon; Julie Rivière; Laure Vescovo; Paule Benit; Isabelle Giscos-Douriez; Aurélien De Reyniès; Jérôme Bertherat; Cécile Badoual; Frédérique Tissier; Laurence Amar; Rosella Libé; Pierre-François Plouin; Xavier Jeunemaitre; Pierre Rustin; Anne-Paule Gimenez-Roqueplo
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.